SIM0500
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SIM0500, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]